CTSO (CytoSorbents) Shiller PE Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CTSO CytoSorbents Corp CTSO
45 GF Score
Price $6.33
GF Value $17.32
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is CytoSorbents Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CytoSorbents  (NAS:CTSO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CytoSorbents Shiller PE Ratio Related Terms


CytoSorbents Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for CytoSorbents's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CytoSorbents Shiller PE Ratio Chart

CytoSorbents Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CytoSorbents Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CTSO vs LFWD, GTHP, PMI: Shiller PE Ratio Comparison

For the Medical Devices subindustry, CytoSorbents's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytoSorbents Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CytoSorbents's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CytoSorbents's Shiller PE Ratio falls into.


CTSO
45GF Score
CytoSorbents Corp CTSO
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CytoSorbents Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CytoSorbents's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, CytoSorbents's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-1.4/333.9520*333.9520
=-1.400

Current CPI (Jun. 2026) = 333.9520.

CytoSorbents Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -1.791 241.428 -2.477
201612 -3.781 241.432 -5.230
201703 -1.194 243.801 -1.636
201706 -1.194 244.955 -1.628
201709 -1.393 246.819 -1.885
201712 -2.189 246.524 -2.965
201803 -1.990 249.554 -2.663
201806 -3.781 251.989 -5.011
201809 -1.990 252.439 -2.633
201812 -3.383 251.233 -4.497
201903 -2.985 254.202 -3.921
201906 -2.189 256.143 -2.854
201909 -4.179 256.759 -5.435
201912 -2.388 256.974 -3.103
202003 -1.990 258.115 -2.575
202006 -1.592 257.797 -2.062
202009 -0.398 260.280 -0.511
202012 -0.199 260.474 -0.255
202103 -1.990 264.877 -2.509
202106 -2.189 271.696 -2.691
202109 -2.985 274.310 -3.634
202112 -4.179 278.802 -5.006
202203 -4.179 287.504 -4.854
202206 -4.975 296.311 -5.607
202209 -5.572 296.808 -6.269
202212 -0.199 296.797 -0.224
202303 -3.383 301.836 -3.743
202306 -2.786 305.109 -3.049
202309 -4.179 307.789 -4.534
202312 -2.651 306.746 -2.886
202403 -2.200 312.332 -2.352
202406 -1.600 314.175 -1.701
202409 -1.000 315.301 -1.059
202412 -2.800 315.605 -2.963
202503 -0.400 319.799 -0.418
202506 0.600 322.561 0.621
202509 -1.000 324.800 -1.028
202512 -1.800 324.054 -1.855
202603 -1.600 330.213 -1.618
202606 -1.400 333.952 -1.400

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is CytoSorbents (CTSO) Overvalued in 2026?

Based on GuruFocus' analysis, CytoSorbents stock appears to be undervalued. The current stock price of $6.33 is trading 63.5% below its estimated GF Value™ of $17.32. GuruFocus considers CytoSorbents to be Possible Value Trap.

Key valuation signals for CTSO:

  • Shiller PE Ratio:
  • GF Value™: $17.32 vs. price of $6.33 (63.5% below fair value)
  • GF Score™: 45/100 with 5 warning signs

No single metric tells the full story. See the CTSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CytoSorbents Business Description

Other Exchanges HQE1:Germany
Address 305 College Road East, Princeton, NJ, USA, 08540
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
45GF Score

Get the complete analysis for CTSO

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.33
Price
$17.32
GF Value